Pyrazine-containing compound
AssigneeCalcimedica, Inc.
InventorsGonul VELICELEBI, Kenneth STAUDERMAN, Michael DUNN, Jack ROOS
Life of this patent
Estimating the term…
Loading patent…
AssigneeCalcimedica, Inc.
InventorsGonul VELICELEBI, Kenneth STAUDERMAN, Michael DUNN, Jack ROOS
Estimating the term…
Compositions and methods related to the amelioration of pancreatitis through the pharmaceutical manipulation of calcium signaling are disclosed. Such compositions and methods may be used to ameliorate symptoms of acute or chronic pancreatitis or to reduce the chance or severity of pancreatitis in an individual at risk of the condition. In other embodiments, disclosed herein are compositions and methods related to the amelioration of viral diseases through the pharmaceutical manipulation of calcium signaling. In further embodiments, disclosed herein are compositions and methods related to the amelioration of Th17-induced diseases through the pharmaceutical manipulation of calcium signaling.
A compound having the chemical name N-(5-(6-chloro-2,2-difluorobenzo[d][1,3]dioxol-5-yl)pyrazin-2-yl)-2-fluoro-6-methylbenzamide or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.